Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Heart ; 89(2): E7, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12527693

ABSTRACT

Protein C deficiency is a disorder in the coagulation cascade that results in predominantly venous thromboembolism. However, recent studies have implicated this disorder as a possible contributor to arterial thrombosis, especially myocardial infarction. There are six reported cases of myocardial infarction secondary to protein C deficiency in the literature. This is the first report of myocardial infarction and ischaemic stroke in the same patient as a manifestation of protein C deficiency. The investigation of hypercoagulable state is an essential component of the investigation of young patients with myocardial infarction.


Subject(s)
Brain Ischemia/etiology , Myocardial Infarction/etiology , Protein C Deficiency/complications , Adult , Coronary Stenosis/etiology , Female , Humans , Magnetic Resonance Angiography , Tomography, X-Ray Computed
2.
Circulation ; 104(18): 2205-9, 2001 Oct 30.
Article in English | MEDLINE | ID: mdl-11684632

ABSTRACT

BACKGROUND: Recent studies have supported the hypothesis that calcific aortic stenosis is the product of an active inflammatory process, with similarities to atherosclerosis. We sought to determine whether therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) might slow the progression of aortic stenosis. METHODS AND RESULTS: A retrospective study of 174 patients (mean age 68+/-12 years) with mild to moderate calcific aortic stenosis was conducted. Patients required normal left ventricular function, /=2 echocardiograms performed at least 12 months apart. Fifty-seven patients (33%) received treatment with a statin; the remaining 117 (67%) did not. The statin group was older and had a higher prevalence of hypertension, diabetes mellitus, and coronary disease. During a mean follow-up of 21 months, patients treated with statin had a smaller increase in peak and mean gradient and a smaller decrease in aortic valve area. When annualized, the decrease in aortic valve area for the nonstatin group was 0.11+/-0.18 cm(2) compared with 0.06+/-0.16 cm(2) for those treated with a statin (P=0.03). In multivariate analysis, statin usage was a significant independent predictor of a smaller decrease in valve area (P=0.01) and a lesser increase in peak gradient (P=0.02). CONCLUSIONS: Statin-treated patients, despite a higher risk profile for progression, had reduced aortic stenosis progression compared with those not treated with a statin. These data provide justification for a prospective randomized trial to substantiate whether statin therapy slows the progression of aortic stenosis.


Subject(s)
Aortic Valve Stenosis/drug therapy , Calcinosis/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Aged , Aortic Valve Stenosis/complications , Aortic Valve Stenosis/diagnostic imaging , Atorvastatin , Calcinosis/complications , Calcinosis/diagnostic imaging , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Disease Progression , Echocardiography , Electrocardiography/drug effects , Fatty Acids, Monounsaturated/therapeutic use , Female , Fluvastatin , Follow-Up Studies , Heptanoic Acids/therapeutic use , Humans , Indoles/therapeutic use , Lovastatin/therapeutic use , Male , Multivariate Analysis , Pravastatin/therapeutic use , Pyrroles/therapeutic use , Retrospective Studies , Risk Factors , Simvastatin/therapeutic use , Treatment Outcome , Triglycerides/blood , Vascular Patency/drug effects
3.
Am J Cardiol ; 86(10): 1097-101, 2000 Nov 15.
Article in English | MEDLINE | ID: mdl-11074206

ABSTRACT

Identification of thrombus-related mechanical prosthetic valve dysfunction (MPVD) has important therapeutic implications. We sought to develop an algorithm, combining clinical and echocardiographic parameters, for prediction of thrombus-related MPVD in a series of 53 patients (24 men, age 52 +/- 16 years) who had intraoperative diagnosis of thrombus or pannus from 1992 to 1997. Clinical and echocardiographic parameters were analyzed to identify predictors of thrombus and pannus. Prevalence of thrombus and diagnostic yields relative to the number of predictors were determined. There were 22 patients with thrombus, 19 patients with pannus, and 12 patients with both. Forty-two of 53 masses were visualized using transesophageal echocardiography (TEE), including 29 of 34 thrombi or both thrombi and panni and 13 of 19 isolated panni. Predictors of thrombus or mixed presentation include mobile mass (p = 0.009), attachment to occluder (p = 0.02), elevated gradients (p = 0.04), and an international normalized ratio of < or = 2.5 (p = 0.03). All 34 patients with thrombus or mixed presentation had > or = 1 predictor. The prevalence of thrombus in the presence of < or = 1, 2, and > or = 3 predictors is 14%, 69%, and 91%, respectively. Thus, TEE is sensitive in the identification of abnormal mass in the setting of MPVD. An algorithm based on clinical and transesophageal echocardiographic predictors may be useful to estimate the likelihood of thrombus in the setting of MPVD. In the presence of > or = 3 predictors, the probability of thrombus is high.


Subject(s)
Echocardiography, Transesophageal , Granulation Tissue/diagnostic imaging , Heart Valve Prosthesis/adverse effects , Thrombosis/diagnostic imaging , Thrombosis/etiology , Aged , Algorithms , Case-Control Studies , Decision Trees , Diagnosis, Differential , Discriminant Analysis , Echocardiography , Echocardiography, Transesophageal/instrumentation , Echocardiography, Transesophageal/methods , Female , Humans , International Normalized Ratio , Likelihood Functions , Male , Middle Aged , Prevalence , Prosthesis Failure , Risk Factors , Sensitivity and Specificity , Thrombosis/blood , Thrombosis/surgery , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...